Page last updated: 2024-12-08

ahc 52

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

AHC 52: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164115
SCHEMBL ID3681208
MeSH IDM0164326

Synonyms (11)

Synonym
ahc 52
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-(1-methylethyl)pyrazolo(1,5-a)pyridin-3-yl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester
119666-09-0
5-o-[2-[benzyl(methyl)amino]ethyl] 3-o-methyl 2,6-dimethyl-4-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)-1,4-dihydropyridine-3,5-dicarboxylate
ahc-52
methyl 2-(n-benzyl-n-methylamino)ethyl-2,6-dimethyl-4-(2-isopropylpyrazolo(1,5-a)pyridine-3-yl)-1,4-dihydropyridine-3,5-dicarboxylate
SCHEMBL3681208
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]-1,4-dihydropyridine-3,5-dicarboxylate
DTXSID80923066
AKOS040750215
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-, 3-methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's6 (85.71)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]